Dog ate a calcium channel blocker: nifedipine, felodipine and related drugs

Recover the name and formulation together

Nifedipine and felodipine belong to the calcium-channel-blocker family. Amlodipine, diltiazem and verapamil are other members, but these names are not interchangeable. Photograph the prescription label and any manufacturer's packaging. Copy release terms, including ER, XR, XL or extended-release, exactly rather than omitting them from the report.

A medicine used for blood pressure may instead be a beta blocker, an ACE inhibitor or ARB, or a diuretic. The treatment purpose cannot identify the drug family. If a pill organizer contains several heart medicines, report all possibly accessible compartments instead of attributing a missing tablet to one prescription by color.

Four distinctions change the cardiac exposure history

This graphic compares information needs. It does not rank individual blockers or supply an ingestion threshold.

What calcium channel blockade changes

The Merck cardiovascular-toxicology reference explains that these drugs affect calcium channels involved in cardiac and vascular function. Excessive exposure can disrupt blood pressure and heart performance; members differ in their emphasis and individual toxicology. A label reading “blood pressure” does not mean the main risk is a symptom an owner can see immediately.

Professional assessment may include blood pressure, ECG rhythm and blood chemistry rather than simply counting the pulse at home. Tell the team about existing heart or kidney disease, diabetes and all medicines already given. A planned veterinary prescription for a member of the family does not make an extra amount, another person's strength or a different blocker safe for this dog.

Visible signs are only part of the picture

Report vomiting, unusual quietness, weakness, stumbling, a noticeable heartbeat change or difficulty breathing. Collapse, seizures or inability to stand is an emergency. Merck describes cardiovascular, gastrointestinal and neurologic findings and potential glucose or electrolyte abnormalities. Absence of one expected sign—for example, a slow heartbeat—does not exclude exposure or imply that a different blocker was harmless.

Do not perform exercise, excitement or a home “response test” to see whether the dog perks up. Keep the dog calmly supervised while following the veterinary team's transport instructions. Write observations with times so the clinician can understand progression. A normal early appearance should be reported as an observation, not used as permission to wait until a dramatic change occurs.

Extended-release is not a safe-delay window

Preserve prolonged-release wording and tell the team if a tablet was chewed. A formulation designed for gradual human dosing can change the clinical course, but it does not promise a fixed period before risk begins. Do not use another drug's onset timeline or an immediate-release capsule's advice to clear an extended-release tablet. The clinician decides the appropriate duration of observation.

Count remaining tablets only if it is quick and safe. Give the possible original count, what remains and the maximum missing amount. If the prescription was recently refilled or the organizer mixed old and new pills, disclose that. A reliable range helps more than presenting an uncertain bottle count as exact. Note missing foil, plastic or other material separately from the medicine.

What not to administer while arranging help

Do not give calcium supplements because the medicine's family name includes calcium. This is not a nutritional deficiency that can be corrected with a household vitamin. Likewise, do not give another person's cardiac drug, an energy product, salt or a vomiting agent. Professional therapies described in a toxicology manual are hospital decisions, not home dosing instructions.

Pet Poison Helpline's emergency instructions support prompt consultation and avoiding unsupervised antidotes or vomiting. Have the weight, label, formulation, amount range and signs ready using the call checklist. Afterward, use pet-inaccessible storage for bottles and organizers; the FDA storage guidance emphasizes that human and pet medicines both need protection from accidental access.